Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Annals of Surgical Oncology, 02/05/08
Dominguez FJ et al. - In a trial to determine the utility of sentinel node biopsy (SNB) for ductal carcinoma in situ (DCIS) and its potential to avoid axillary lymph node dissection (ALND) in patients undergoing mastectomy for DCIS, it was found that 11% of patients undergoing mastectomy for DCIS had invasive cancer on final pathology; use of SNB during mastectomy for DCIS allowed nearly all such patients to avoid axillary dissection
Methods- A review was conducted of 179 patients who underwent mastectomy with sentinel node biopsy for DCIS without invasion or microinvasion on premastectomy pathology review
- Sentinel node identification rate was 98.9%
- 11.3% of mastectomies for DCIS had a positive SNB: 2 micrometastasis (pN1mi) and 18 isolated tumor cells [pN0(i+)]
- Unsuspected invasive cancer was found in 11.2% of the mastectomies, 8 T1mic, 5 T1a, 3 T1b, and 4 T1c tumors
- Sentinel nodes were identified in 19 of 20 patients with invasive cancer and 4 were positive: 1 pN1mi and 3 pN0(i+)
- 18 of 19 patients with unsuspected invasive cancer were able to avoid axillary dissection on the basis of SNB results
- Of the 159 patients whose final pathology revealed DCIS without invasion, a sentinel node was identified in 99.4%
- SNB was positive in 16 patients: 1 pN1mi and 15 pN0(i+)
- 3 patients underwent ALND on the basis of positive SNBs and in each the SNB was the only positive node
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group
Journal of Clinical Oncology, 10/19/09
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
Annals of Oncology, 10/13/09
Pomegranate fruit extract impairs invasion and motility in human breast cancer
Integrative Cancer Therapies , 10/12/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Nonsteroidal anti-inflammatory drugs
Cancer, 10/16/09
Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial
Annals of Oncology, 10/13/09
Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


